Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl
Delhi Development Authority
SOUTH DELHI, DELHI
Bid Publish Date
16-Jul-2025, 9:02 am
Bid End Date
02-Aug-2025, 9:00 am
Value
₹2,42,649
Location
Progress
RAQuantity
63870
Office Of Dg ( Med & Cos) announces a tender for Title1, Title2, Title3, Title4, Title5, Title6, Title7, Title8, Title9, Title10, Title11, Title12, Title13, Title14, Title15, Title16, Title17, Title18, Title19, Title20, Title21, Title22, Title23, Title24, Title25, Title26, Title27, Title28, Title29, Title30, Title31, Title32, Title33, Title34, Title35, Title36, Title37, Title38, Title39, Title40, Title41, Title42, Title43, Title44 in Samba, JAMMU & KASHMIR. Quantity: 63870. Submission Deadline: 02-08-2025 09: 00: 00. Last date to apply is approaching fast!
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Delhi Development Authority
SOUTH DELHI, DELHI
N/a
Delhi Development Authority
SOUTH WEST DELHI, DELHI
Cpwd
BILASPUR, CHHATTISGARH
Central University Of Haryana
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Title1 | Pregabalin 75 mg Cap | 9,000 | no | jeril | 30 |
| 2 | Title2 | Gabapentin 300 mg Cap | 1,800 | no | jeril | 30 |
| 3 | Title3 | Phenytoin Sodium 100 mg Tab | 3,000 | no | jeril | 30 |
| 4 | Title4 | Sodium Valproate 200 mg Tab | 300 | no | jeril | 30 |
| 5 | Title5 | Baclofen 10 mg Tab | 600 | no | jeril | 30 |
| 6 | Title6 | Tranexamic Acid 500 mg per 5ml Inj | 120 | amp | jeril | 30 |
| 7 | Title7 | S Amlodipine 5mg Tab | 9,000 | no | jeril | 30 |
| 8 | Title8 | Amlodipine 10 mg Tab | 1,200 | no | jeril | 30 |
| 9 | Title9 | Choline Salicylate and Lignocaine Hydrochloride Gel Tube of 10 gm | 300 | tube | jeril | 30 |
| 10 | Title10 | Clindamycin phosphate 1 percen topical gel Tube of 10 gm | 600 | tube | jeril | 30 |
| 11 | Title11 | Clotrimazole Pulv 1 percen Bott of 75 gm | 300 | bott | jeril | 30 |
| 12 | Title12 | Fexofenadine 180 mg Tab | 6,000 | no | jeril | 30 |
| 13 | Title13 | Framycetin sulphate BP 1 percen cream 20 gm | 300 | tube | jeril | 30 |
| 14 | Title14 | Mometasone 0 point 1 percen tube of 10 gm | 480 | tube | jeril | 30 |
| 15 | Title15 | Permethrin Lotion 5 percen Bott of 50 ml | 240 | bott | jeril | 30 |
| 16 | Title16 | Para dichlorobenzene Benzocaine Chlorbutourpentine T oil bott 10 ml | 120 | bott | jeril | 30 |
| 17 | Title17 | Frusemide 40 mg Tab | 600 | no | jeril | 30 |
| 18 | Title18 | Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCl 10 mg | 1,200 | no | jeril | 30 |
| 19 | Title19 | Trypsin with chymotrypsin Tab | 3,000 | no | jeril | 30 |
| 20 | Title20 | Sucralfate Suspension 1gm per 5ml bott of 200 ml | 240 | bott | jeril | 30 |
| 21 | Title21 | Metoclopramide 10 mg Tab | 900 | no | jeril | 30 |
| 22 | Title22 | Isapgol husk 3 point 5 gm | 2,400 | sachet | jeril | 30 |
| 23 | Title23 | Bisacodyl 5 mg Tab | 600 | no | jeril | 30 |
| 24 | Title24 | Dydrogesterone 10mg Tab | 360 | no | jeril | 30 |
| 25 | Title25 | Natural Micronised Progesterone 100 mg Tab | 1,200 | no | jeril | 30 |
| 26 | Title26 | Ciprofloxacin HCl 0 point 3 percen Dexamethasone 0 point 1 percen bott of 5ml | 180 | bott | jeril | 30 |
| 27 | Title27 | Moxifloxacin 0 point 5 percen preservative free Eye drops | 150 | bott | jeril | 30 |
| 28 | Title28 | Betahistine Dihydrochloride 8mg Tab | 1,800 | no | jeril | 30 |
| 29 | Title29 | Clotrimazole 1 percen w v IP Lignocaine 2 percen w v IP ear drop bott of 10ml | 360 | bott | jeril | 30 |
| 30 | Title30 | Nasal adult drops Xylometazoline 0 point 1 per nasal drop bott of 10 ml | 300 | bott | jeril | 30 |
| 31 | Title31 | Cyproheptadine HCl 2 mg per 5 ml bott of 100 ml | 180 | bott | jeril | 30 |
| 32 | Title32 | Metronidazole susp 200 mg per 5ml bott of 60 ml | 300 | bott | jeril | 30 |
| 33 | Title33 | Alprazolam 0 point 25 mg Tab | 2,400 | no | jeril | 30 |
| 34 | Title34 | Syp Terbutaline Bromhexine Guaiphenesin bott of 100 ml | 600 | no | jeril | 30 |
| 35 | Title35 | Dextrose 50 percen 25 ml Inj | 60 | amp | jeril | 30 |
| 36 | Title36 | Potassium Citrate Citric Acid bott of 200ml | 360 | bott | jeril | 30 |
| 37 | Title37 | Iron Syp Paed elemental Iron 25-50 mg and Folic Acid 500 mcg bott of 200 ml | 300 | no | jeril | 30 |
| 38 | Title38 | Monteleukast 5 mg Tab | 7,200 | no | jeril | 30 |
| 39 | Title39 | Glucosamine 500 mg Tab | 3,000 | no | jeril | 30 |
| 40 | Title40 | Glucosamine 250 mg Chondroitin Sulphate 200 mg Cap | 900 | no | jeril | 30 |
| 41 | Title41 | Tab Etoricoxib 90 mg | 1,200 | no | jeril | 30 |
| 42 | Title42 | Corn cap pack of 4 | 60 | pkt | jeril | 30 |
| 43 | Title43 | Miconazole Nitrate Cream IP 2 point 0 percen tube of 30 g | 300 | tube | jeril | 30 |
| 44 | Title44 | Tab Flunarizine 10 mg | 360 | no | jeril | 30 |
Discover companies most likely to bid on this tender
Extended Deadline
02-Aug-2025, 9:00 am
Opening Date
02-Aug-2025, 9:30 am
Start
03-Aug-2025, 1:00 pm
End
07-Aug-2025, 9:00 am
Duration: 92 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Key insights about JAMMU AND KASHMIR tender market
This tender encompasses a wide array of pharmaceutical and medical product supplies, primarily focused on anti-tuberculosis (TB) drugs, first-line anti-TB medicines, anti-retroviral medications, analgesics, and topical medicines. Here is a high-level overview:
| Main Product Categories | Quantity | Purpose |
|---|---|---|
| Anti TB Drugs | approx. | For treatment of tuberculosis in defence and public health sectors |
| First Line Anti TB Drugs | Including Isoniazid, Ethambutol, Rifampicin, Cycloserine, Levofloxacin, Moxifloxacin | |
| Anti-Retroviral Medications | Lamivudine, Dolutegravir, Tenofovir Disoproxil Fumarate, Zidovudine, Nevirapine, etc. | |
| Analgesics & Anti-inflammatory | Diclofenac, Mefenamic Acid, Paracetamol, Betahistine, etc. | |
| Topical & Syrup Formulations | Clindamycin gel, Fexofenadine + Montelukast, Frusemide, Dextrose injections |
Key Details:
🔍 Note: The specific contract value is not disclosed in the tender document, so interested bidders should focus on compliance, quality standards, and meeting technical specifications.
Participation in this tender affords:
✅ MSE & Startup Benefits:
✅ Additional Benefits:
🔴 Mandatory Documents to Submit:
Note: Missing critical documents can result in disqualification during bid evaluation.
🚚 Delivery Locations:
Multiple designated departmental sites across India as specified in the tender documents. Exact locations will be provided post registration and during tender submission.
⏱️ Timeline & Delivery Schedule:
Pro Tip: Plan your logistics considering regional accessibility and customs clearance, if applicable, for smooth execution.
⚠️ Important:
💡 Winning Strategies:
🎯 Strengthen your chances:
Seize this excellent opportunity to contribute to and profit from a major government procurement initiative. Engaging in this tender not only promises commercial growth but also strengthens your role as a vital supplier for India’s defence and healthcare sectors.
🔗 Get professional support with GeM registration and bid strategies at TenderAI Services.
Ensure your documents are in order, meet all standards, and participate confidently before the deadline on 26th July 2025.
Start preparing today and turn this government procurement into your next success story!
Q1: How to register on GeM portal for defence medical supplies tender in India?
To participate in government tenders like this one, it is essential to complete your registration on the GeM portal. Visit TenderAI GeM Registration for professional assistance in creating a verified vendor profile. The process involves providing business registration certificates, GST details, and product certifications. Proper registration enhances your credibility and visibility among government buyers, simplifying the bid submission process. Ensure all documentation is current and complies with Indian regulations to avoid rejection or delays. TenderAI experts can guide you through documentation, profile setup, and compliance that aligns with defence procurement standards. Once registered, you will be able to access the tender documents, submit quotes, and participate directly.
Q2: What are the eligibility requirements to supply pharmaceuticals to the Department of Defence Research & Development in India?
Eligibility criteria include possessing valid drug licenses (such as Drug Control Licenses), ISO certifications, GST registration, and compliance with Indian Pharmacopoeia standards. Bidders should demonstrate manufacturing or supply experience in pharmaceuticals, particularly in high-volume government projects. Startups and SMEs benefit from priority schemes, including price preferences and simplified registration processes. It is crucial to maintain quality standards, proper documentation, and past performance records. For detailed eligibility verification, consult official tender documents, or seek assistance from TenderAI to ensure comprehensive compliance.
Q3: How do I prepare my bid for the defence medical supplies tender scheduled for July 2025?
Begin by gathering all necessary documents: manufacturing licenses, quality certificates, experience letters, and bid security receipts. Carefully review the detailed product specifications, quantity requirements, and delivery schedules specified in the tender. Use the official portal to fill technical and financial bid forms, ensure accuracy, and double-check uploaded documents. Consider leveraging TenderAI’s bid optimization services for technical clarity and presentation. Submit your bid before the deadline of 26th July 2025 at 09:00 AM. Post-submission, track your bid status online and prepare for evaluation or clarification calls if needed.
Q4: Are there any benefits for startups and MSMEs participating in defence sector tenders like this one?
Yes, startups and MSMEs receive several advantages, including enhanced visibility through government schemes, bid price preferences, and promotional support under the Make in India initiative. They may also get priority processing and relaxed eligibility criteria if certain benchmarks are met. This opens pathways to long-term government procurement, increasing revenue and market credibility. To capitalize on this, ensure your documentation clearly highlights your company’s capabilities, certifications, and compliance with technical specifications. Leverage TenderAI’s services to streamline registration and bidding processes, increasing your chances of success.
Q5: What are the documentation standards required for supplying anti-TB and pharmaceutical products to Indian government agencies?
Suppliers must hold valid licenses from Indian drug regulatory authorities, including licensing certificates compliant with the Drugs and Cosmetics Act. Additional documentation includes ISO certifications, Manufacturing Compliance Certificates, Batch Testing Reports, and GMP compliance. Accurate product datasheets, sample testing reports, and adherence to Indian Pharmacopoeia are mandatory. Regular updates of licenses and certifications are necessary to participate in ongoing tenders. TenderAI’s compliance experts can assist in preparing and auditing your documents to meet all specifications, preventing disqualification during technical evaluation.
Q6: How can I ensure timely delivery of large medicine consignments to government agencies?
Effective logistics planning is essential. Establish reliable transportation channels, coordinate with approved couriers, and plan for regional accessibility challenges. Always factor in potential delays due to customs, weather, or regional regulations. Maintain detailed delivery schedules, inventory management, and tracking systems. Using advanced planning tools and TenderAI’s logistics consulting services can optimize delivery routes and schedules. Start preparing your supply chain well in advance to meet the requirements specified in the bid and avoid penalties for late delivery.
Q7: How do I understand the evaluation criteria for securing this defence medical procurement in India?
Evaluation is typically based on technical compliance, bid price, past performance, and quality certifications. Bidders demonstrating robust manufacturing capacity, compliance with standards, and competitive pricing have higher chances of success. Make sure your bid documents clearly showcase your technical capabilities, quality assurance procedures, and delivery timelines. The government may also prioritize local manufacturers and small enterprises. Reviewing previous similar contract awards and consulting TenderAI’s market insights can help tailor your bid effectively.
Q8: What precautions should I take while preparing the bid to avoid disqualification?
Ensure all mandatory documents, licenses, and certifications are current, accurate, and properly uploaded. Read tender instructions carefully—pay close attention to product specifications, delivery deadlines, and bid security requirements. Avoid errors or discrepancies in pricing, technical details, and supporting documents. Maintain transparency and compliance with all legal and regulatory norms. Utilizing expert consultation from TenderAI can help check your bid for compliance gaps and procedural errors, reducing disqualification risk.
Q9: How can I improve my chances of winning large government pharmaceutical tenders in India?
Focus on quality, compliance, and timely delivery. Build a strong track record with previous government supplies, secure necessary certification approvals, and maintain competitive pricing. Establish reliable supply chains and inventory management systems. Participate actively in pre-bid meetings for clarifications. Use TenderAI’s insights and bid optimization tools to develop winning strategies tailored to government requirements. Maintain transparency and uphold ethical standards to build long-term credibility.
Q10: How do I start the process after my bid is accepted for this defence procurement?
Post-acceptance, you will receive detailed instructions for contract signing, delivery timelines, and quality inspections. Ensure your manufacturing and supply chain are prepared to meet contractual commitments. Maintain open communication with the procurement authority for updates and queries. Use project management tools to track delivery milestones, and regularly verify compliance with quality standards. For ongoing support, consult TenderAI’s post-bi analysis and supplier performance tracking services to strengthen future procurement opportunities.
Take the first step today—register on GeM, prepare your documentation, and leverage expert support from TenderAI. Participate confidently and turn this strategic opportunity into a significant growth milestone!
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS